Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    November 2017
  1. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4194.
    PubMed     Text format     Abstract available


  2. LV XY, Ma L, Chen JF, Yu R, et al
    Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4195.
    PubMed     Text format     Abstract available


    August 2017
  3. SUN Y, Guan Z, Zhao W, Jiang Y, et al
    Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-kappaB signal-dependent and signal-independent manner.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4089.
    PubMed     Text format     Abstract available


  4. YAMASHITA T, Higashi M, Momose S, Morozumi M, et al
    Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
    Int J Oncol. 2017;51:579-586.
    PubMed     Text format     Abstract available


    May 2017
  5. XIONG Y, Huang F, Li X, Chen Z, et al
    CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4003.
    PubMed     Text format     Abstract available


  6. CHEN M, Lv JM, Ye JQ, Cui XG, et al
    Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3997.
    PubMed     Text format     Abstract available


  7. KIM WT, Seo SP, Byun YJ, Kang HW, et al
    Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3993.
    PubMed     Text format     Abstract available


    April 2017
  8. FENG C, Sun P, Hu J, Feng H, et al
    miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3969.
    PubMed     Text format     Abstract available


  9. WANG CY, Xu ZB, Wang JP, Jiao Y, et al
    Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Int J Oncol. 2017;50:1221-1232.
    PubMed     Text format     Abstract available


  10. LIU Z, Liu J, Zhao L, Geng H, et al
    Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
    Int J Oncol. 2017;50:1321-1329.
    PubMed     Text format     Abstract available


    March 2017
  11. HUSSAIN SA, Palmer DH, Syn WK, Sacco JJ, et al
    Gene expression profiling in bladder cancer identifies potential therapeutic targets.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3893.
    PubMed     Text format     Abstract available


  12. HUSSAIN SA, Ansari J, Huddart R, Power DG, et al
    VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in t
    Int J Oncol. 2017;50:768-772.
    PubMed     Text format     Abstract available


    December 2016
  13. WANG JP, Jiao Y, Wang CY, Xu ZB, et al
    Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3791.
    PubMed     Text format     Abstract available


  14. CHEN L, Wang G, Luo Y, Wang Y, et al
    Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3788.
    PubMed     Text format     Abstract available


    November 2016
  15. KAMEYAMA K, Horie K, Mizutani K, Kato T, et al
    Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.
    Int J Oncol. 2016 Nov 24. doi: 10.3892/ijo.2016.3781.
    PubMed     Text format     Abstract available


    September 2016
  16. CHOI EO, Park C, Hwang HJ, Hong SH, et al
    Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
    Int J Oncol. 2016;49:1009-18.
    PubMed     Text format     Abstract available


    April 2016
  17. LI QQ, Hao JJ, Zhang Z, Hsu I, et al
    Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3478.
    PubMed     Text format     Abstract available


    March 2016
  18. ZHANG Y, Liu W, He W, Zhang Y, et al
    Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
    Int J Oncol. 2016 Mar 3. doi: 10.3892/ijo.2016.3415.
    PubMed     Text format     Abstract available


    January 2016
  19. XIE X, Pan J, Wei L, Wu S, et al
    Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
    Int J Oncol. 2016 Jan 25. doi: 10.3892/ijo.2016.3357.
    PubMed     Text format     Abstract available


    November 2015
  20. SUN Y, Guan Z, Liang L, Cheng Y, et al
    NF-kappaB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Int J Oncol. 2015 Nov 20. doi: 10.3892/ijo.2015.3256.
    PubMed     Text format     Abstract available


    September 2015
  21. HUANG YT, Cheng CC, Chiu TH, Lai PC, et al
    Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer.
    Int J Oncol. 2015 Sep 11. doi: 10.3892/ijo.2015.3155.
    PubMed     Text format     Abstract available


    August 2015
  22. ZHANG S, Zhang C, Liu W, Zheng W, et al
    MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Int J Oncol. 2015 Aug 7. doi: 10.3892/ijo.2015.3117.
    PubMed     Text format     Abstract available


    July 2015
  23. RIEGER C, Huebner D, Temme A, Wirth MP, et al
    Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Int J Oncol. 2015 Jul 20. doi: 10.3892/ijo.2015.3096.
    PubMed     Text format     Abstract available


    June 2015
  24. GAO Y, Guan Z, Chen J, Xie H, et al
    CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Int J Oncol. 2015 Jun 9. doi: 10.3892/ijo.2015.3041.
    PubMed     Text format     Abstract available


    May 2015
  25. MATSUSHIMA M, Kikuchi E, Matsumoto K, Hattori S, et al
    Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
    Int J Oncol. 2015 May 11. doi: 10.3892/ijo.2015.2995.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: